DigitalCIO
No Result
View All Result
  • Home
  • Tech News
  • Market Insights
  • CIO Interviews
  • Events and Conferences
  • Opinion and Analysis
  • Resources
DigitalCIO
  • Home
  • Tech News
  • Market Insights
  • CIO Interviews
  • Events and Conferences
  • Opinion and Analysis
  • Resources
No Result
View All Result
Digitalcio
No Result
View All Result
Home Tech News

Researchers develop AI tool to predict cell behaviour during diseases, treatment

DigitalCIO Bureau by DigitalCIO Bureau
July 30, 2019
in Tech News
0
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter

Source: IANS

Researchers have developed — scGen — an Artificial Intelligence (AI)-powered tool which promises to reshape the way we study diseases and their treatment at cellular level.

Researchers have developed — scGen — an Artificial Intelligence (AI)-powered tool which promises to reshape the way we study diseases and their treatment at cellular level.

The study, published in the journal Nature Methods, shows scGen will help mapping and studying cellular response to diseases and their treatment beyond experimentally available data.

According to the researchers, scGen is a generative deep learning model that leverages ideas from image, sequence and language processing and applies them to model the behaviour of a cell performed on computer or via computer simulation.

The next step for the team will be to improve scGen, make it a fully data-driven formulation, increasing its predictive power to enable the study of combinations of perturbations.

“We can now start optimising scGen to answer more and more complex questions about diseases,” said the researcher Alex Wolf from the Technical University of Munich in Germany.

Large-scale atlases of organs in a healthy state are soon going to be available, in particular, within the Human Cell Atlas. This is a significant step in understanding cells, tissues and organs in healthy state in a better way and providing a reference while diagnosing, monitoring and treating diseases.

Accurately modelling cellular response to perturbations e.g. disease, compounds and genetic interventions, is a central goal of computational biology.

In addition, scGen is the first tool that predicts cellular response out-of-sample. This means that scGen, if trained on data that captures the effect of perturbations for a given system, is able to make reliable predictions for a different system.

“For the first time, we have the opportunity to use data generated in one model system such as mouse and use the data to predict disease or therapy response in human patients,” said Mohammad Lotfollahi from Technical University of Munich.

Share30Tweet19
DigitalCIO Bureau

DigitalCIO Bureau

Recommended For You

Digital Fraud Overtakes Ransomware as CEOs’ Biggest Concern

by DigitalCIO Bureau
January 19, 2026
0
Retail Industry — Next Big Target for Hackers?

Artificial intelligence, geopolitical fragmentation and a surge in cyber-enabled fraud are redefining the global cyber risk landscape at unprecedented speed, according to the World Economic Forum’s Global Cybersecurity Outlook...

Read moreDetails

Cyera Secures $400M Series F, Hits $9B Valuation

by DigitalCIO Bureau
January 13, 2026
0
Cyera Secures $400M Series F, Hits $9B Valuation

Cyera has announced a $400 million Series F funding round, bringing its total funding to over $1.7 billion. This raise comes just six months after the previous round...

Read moreDetails

Trend Micro Closes Vulnerabilities in Apex Central

by DigitalCIO Bureau
January 9, 2026
0
Financial organizations receive an average of 2200+ application security vulnerability alerts every month: Dynatrace CISO Regional Bank 2023 report

The National Cyber ​​Security Centre (NCSC) is warning of vulnerabilities in Trend Micro Apex Central. These vulnerabilities could potentially cause a Denial-of-Service (DoS) attack. Updates addressing the vulnerability...

Read moreDetails

Aditya Birla Ventures invests in GenAI Company Articul8 AI

by DigitalCIO Bureau
January 9, 2026
0
AMD Acquires Open-Source AI Software Expert Nod.ai

Aditya Birla Ventures has announced its investment in the first tranche of Articul8 AI, Inc.’s oversubscribed Series B financing round. Articul8 AI, an enterprise generative AI (GenAI) software...

Read moreDetails

Snowflake Acquires Observe

by DigitalCIO Bureau
January 9, 2026
0
CRISIL To Acquire Bridge To India Energy

Snowflake has signed a definitive agreement to acquire Observe, a leader in AI-powered observability. With this acquisition, Snowflake will deliver the next generation of AI-powered observability, built on open standards...

Read moreDetails
Next Post

How Artificial Intelligence is Impacting the Automotive Industry

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Phil Venables Joins Board of Infoblox

Phil Venables Joins Board of Infoblox

August 23, 2025

VIAVI Releases Industry Data on The State of 5G Deployments Worldwide

February 19, 2019
AMD Acquires Open-Source AI Software Expert Nod.ai

Rubrik Buys AI Startup Predibase

June 27, 2025

Browse by Category

  • Acquisition
  • Appointment
  • Archive
  • Artificial Intelligence
  • CIO Interviews
  • Cloud
  • Datacenter
  • Events and Conferences
  • Market Insights
  • News
  • Opinion and Analysis
  • Products
  • Resources
  • Security
  • Storage
  • Tech News
  • Telecom
Digitalcio

Welcome to DigitalCIO, your ultimate source for staying ahead in the ever-evolving world of technology and business.

BROWSE BY TAG

Acquisition AI Appointment artificial intelligence Artificial Intelligence and Machine Learning AWS Barracuda Big Data and Analytics Blockchain CISCO Cloud Computing Cloudflare Commvault CrowdStrike Cybersecurity Digital Transformation Dynatrace E-books Fortinet Gartner GenAI Generative AI Google Cloud IBM Infographics Internet of Things (IoT) Kaspersky Microsoft New Relic NTT DATA NVIDIA Palo Alto Networks Panel Discussion Qlik Salesforce ServiceNow Sophos Tenable Trend Micro Veeam Veeam Software Vertiv Webinars Whitepaper Zscaler

CATEGORIES

  • Tech News
  • Market Insights
  • CIO Interviews
  • Events and Conferences
  • Opinion and Analysis
  • Resources
  • Archive

NAVIGATION

  • Home
  • About Us
  • Advertise with Us
  • Contact Us

© 2024 digitalcio.in - All rights reserved.

No Result
View All Result
  • Home
  • Tech News
  • Market Insights
  • CIO Interviews
  • Events and Conferences
  • Opinion and Analysis
  • Resources

© 2024 digitalcio.in - All rights reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?